Dr. Boyd, a cancer researcher and genomics expert, also was appointed a professor and member of the Cold Spring Harbor Laboratory Cancer Center.
In his new position, he will develop a molecular diagnostics laboratory for the Northwell’s cancer institute as well as focus on academic relationships with the health system’s scientific collaborators, Northwell said in a news release.
Dr. Boyd most recently was associate deputy director, translational research and genomic medicine, at the Miami Cancer Institute at Baptist Health South Florida. He also served as professor and chair of the department of human and molecular genetics, professor of obstetrics and gynecology and associate dean for basic research and graduate programs at Florida International University’s Herbert Wertheim College of Medicine in Miami.
He currently serves on the Society of Gynecologic Oncology board of directors.
More articles on executive moves:
Douwe Bergsma named chief marketing officer of Piedmont Healthcare
Ascension names new senior VP, Michigan market executive
Jennifer DeCubellis named Hennepin Healthcare CEO
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
